New research uncovers how cannabis addiction, not casual use, is genetically tied to severe mental health conditions, raising red flags for policy, treatment, and prevention. Study: The genetic relationship between cannabis use disorder, cannabis use and psychiatric disorders. Image credit: PeopleImages.com – Yuri A/Shutterstock.com In a recent study published in the journal Nature Mental Health, researchers in … Read more
Mental Health, Retinal Disease Linked: Study Shows Higher Risk Table of Contents Mental Health, Retinal Disease Linked: Study Shows Higher Risk mental health link: bipolar, depression tied to higher risk of retinal disease, vision loss the connection between mental health and vision key findings at a glance did you know? study methodology the numbers behind … Read more
TOPLINE: Individuals older than 50 years with bipolar or major depressive disorder were more likely to have retinal disease, and those with a diagnosis of retinal disease and a psychiatric illness were at sharply higher risk for impaired vision than those with retinal disease alone. METHODOLOGY: Researchers conducted a retrospective cohort analysis of adults aged … Read more
Confront the crucial interplay between sleep and mental health. Discover how insomnia can significantly worsen conditions like anxiety and depression, creating a vicious cycle that demands attention. This piece unravels the complex relationship,exploring how inflammation,triggered by sleep deprivation,fuels psychiatric disorders. Learn about the specific connection between disordered eating, mental health issues, and poor sleep quality. … Read more
Schizophrenia Event Chandigarh MindPlus, a regional pioneer in holistic mental health care, organized session today at MindPlus Doraha to mark World Schizophrenia Day. LUDHIANA, PUNJAB, INDIA, May 24, 2025 /EINPresswire.com/ — On the occasion of World Schizophrenia Day, observed annually on May 24th, MindPlus observes World Schizophrenia Day with an Awareness Session at MindPlus Doraha … Read more
LOS ANGELES — The novel phosphodiesterase 10A (PDE10A) inhibitor known as CPL’36 (Celon Pharma) is effective and generally safe in acute exacerbations of schizophrenia, new research suggested. In a phase 2 trial of 189 patients with acute schizophrenia, compared with the placebo group, the groups receiving CPL’36 20 or 40 mg once daily both met … Read more
Summary: A new study has uncovered a biological link between inflammation and motivational deficits in people with schizophrenia, identifying a promising treatment target for symptoms that current medications fail to address. Higher levels of the inflammatory marker C-reactive protein were associated with reduced activity in brain regions involved in reward and motivation, such as the … Read more
Newborn babies with a vitamin D deficiency have a higher chance of later developing mental disorders such as ADHD, schizophrenia and autism, a major study involving The University of Queensland has found. In the largest population study of its kind, researchers examined vitamin D status of 71,793 people, many of whom had a mental health … Read more
Many women struggle to find resources to help manage their menopause symptoms. For women living with a serious mental illness, the need for additional support and education during the menopause transition is even greater. A new scoping review confirmed the paucity of research on this topic and suggested a need for more psychoeducation programs. Results … Read more
Summary: A new study has found that delusions typically emerge before hallucinations in individuals at high risk for psychosis, overturning a long-standing belief that hallucinations drive delusional thinking. By analyzing symptom progression across three large cohorts, researchers consistently observed that delusions were the earliest symptom, reappearing even before hallucinations during relapses. The study suggests that … Read more